PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.07
0.06 - 0.24
4.46M / 3.59M (Avg.)
-1.65 | -0.04
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-7.99
Both companies show losses. Martin Whitman would check if industry conditions create special situations.
1.56
Similar P/S to CRN.AX's 1.51. David Dodd would investigate if similar multiples reflect similar business quality.
1.09
P/B 1.25-1.5x CRN.AX's 0.74. Martin Whitman would scrutinize if premium reflects better growth prospects.
-11.02
Negative FCF while CRN.AX shows P/FCF of 50.98. Joel Greenblatt would examine cash flow improvement potential.
-15.82
Negative operating cash flow while CRN.AX shows P/OCF of 12.69. Joel Greenblatt would examine operational improvement potential.
1.09
Fair value ratio 1.25-1.5x CRN.AX's 0.74. Martin Whitman would scrutinize if premium reflects better prospects.
-3.13%
Both companies show losses. Martin Whitman would check for industry-wide issues.
-9.07%
Negative FCF while CRN.AX shows yield of 1.96%. Joel Greenblatt would examine cash flow improvement potential.